CTXR

Citius Pharmaceuticals (CTXR)

About Citius Pharmaceuticals (CTXR)

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Details

Daily high

$1.11

Daily low

$1.04

Price at open

$1.05

52 Week High

$5.95

52 Week Low

$0.65

Market cap

19.6M

Dividend yield

0.00%

Volume

931

Avg. volume

556,277

P/E ratio

-.21

Citius Pharmaceuticals News